NOCCR Knoxville is currently seeking adults between the ages of 18-75 with mild, moderate, or severe kidney disease to participate in a clinical research trial.
This is a phase I, open-label, single-dose study of AL-335, an investigational oral medication in development for the treatment of Hepatitis C.
Volunteers must be willing to stay overnight in the study center for 5 days and 4 nights. Compensation up to $1300 is available for expenses and travel.
To learn if you might qualify, please complete the brief questionnaire for this study, or call or office at 865-305-DRUG(3784) to speak with a patient recruitment representative.